These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1063128)

  • 21. In vivo growth and antigenic properties of a rat sarcoma induced by Moloney sarcoma virus.
    Jones JM; Jensen F; Veit B; Feldman JD
    J Natl Cancer Inst; 1974 Jun; 52(6):1771-7. PubMed ID: 4134500
    [No Abstract]   [Full Text] [Related]  

  • 22. The lymphocyte response to primary Moloney sarcoma virus tumors: definition of a non-specific component of the in vitro cellular hyporeactivity of tumor-bearing hosts.
    Kiessling R; Bataillon G; Lamon EW; Klein E
    Int J Cancer; 1974 Nov; 14(5):642-8. PubMed ID: 4459279
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: differential activity of IgG and IgM with different subpopulations of lymphocytes.
    Lamon EW; Shaw MW; Goodson S; Lidin B; Walia AS; Fuson EW
    J Exp Med; 1977 Feb; 145(2):302-13. PubMed ID: 833543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological studies in murine osteosarcoma. Immunogenicity, growth kinetics, and immunotherapy.
    Miller CW; DeBlasi RF; Fisher SJ
    J Bone Joint Surg Am; 1976 Apr; 58(3):312-7. PubMed ID: 1063129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative immunological studies on cryosurgery and surgical operation using Moloney murine sarcoma virus-induced primary tumors in BALB/c mice.
    Kimura H
    Gan; 1978 Aug; 69(4):507-15. PubMed ID: 710802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor effects of doxorubicin against a virally-induced rat osteosarcoma with minimal immunosuppression.
    Kempf RA; Cebul RD; Mitchell MS
    J Immunopharmacol; 1980; 2(4):509-25. PubMed ID: 6937562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of in vitro-stimulated immune lymphocytes in mice bearing Moloney murine sarcoma virus-induced primary tumor.
    Kimura H; Yamaguchi Y
    Gan; 1981 Feb; 72(1):72-80. PubMed ID: 7274651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
    Plata F; Cerottini JC; Brunner KT
    Eur J Immunol; 1975 Apr; 5(4):227-33. PubMed ID: 185057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous tumor regression: possible relationship to in vitro parameters of tumor immunity.
    Hellström KE; Hellström I
    Natl Cancer Inst Monogr; 1976 Nov; 44():131-4. PubMed ID: 193017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro cytolytic activity of human NK cells against osteosarcoma cell lines.
    Tarozzi A; Mariani E; Facchini A
    Boll Soc Ital Biol Sper; 1995; 71(7-8):221-6. PubMed ID: 8519499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating immune complexes in human osteosarcoma.
    Tsang KY; Singh I; Blakemore WS
    J Natl Cancer Inst; 1979 Apr; 62(4):743-8. PubMed ID: 285287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Light and electron microscope studies of osteosarcomas induced in rats and hamsters by Harvey and Moloney sarcoma viruses.
    Fujinaga S; Poel WE; Dmochowski L
    Cancer Res; 1970 Jun; 30(6):1698-708. PubMed ID: 4318698
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunology of sarcomas.
    Mitchell MS
    Clin Orthop Relat Res; 1980; (153):26-30. PubMed ID: 6160937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
    Ryser JE; Cerottini JC; Brunner KT
    Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological, biological, immunological and biochemical studies on bone tumors of animals and man.
    Dmochowski L
    Recent Results Cancer Res; 1976; (54):166-84. PubMed ID: 189370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes.
    Leclerc JC; Cantor H
    J Immunol; 1980 Feb; 124(2):846-50. PubMed ID: 6243332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor cells from tumor-bearing mice.
    Glaser M; Kirchner H; Holden HT; Herberman RB
    J Natl Cancer Inst; 1976 Apr; 56(4):865-7. PubMed ID: 1255803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre- and postoperative studies of in vitro cell-mediated reactivity in canine osteosarcoma.
    Bech-Nielsen S; Reif JS; Brodey RS
    Am J Vet Res; 1978 Jan; 39(1):87-93. PubMed ID: 272858
    [No Abstract]   [Full Text] [Related]  

  • 40. Genetic association of the humoral and cellular immune responses of rats to Moloney sarcomas.
    Veit BC; Jones JM; Miller GA; Feldman JD
    Int J Cancer; 1977 Jan; 19(1):97-106. PubMed ID: 401773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.